Introduction
Of the 60 different types of human papillomavirus (HPV) known, 22 have been found to infect the genital tract (De Villiers, 1989; zur Hausen, 1989 ). An aetiological role for certain types of HPV (e.g. in genital tumours has been supported by the detection of HPV DNA in over 90% of cervical cancers and its frequent occurrence in other genital cancers. Of the HPV types associated with tumours, HPV-16 occurs in 50%, HPV-18 in 20% and HPV-31 and -33 in 5 to 10% each of cervical cancers (Boshart et al., 1984; Diirst et al., 1983; Gissmann et al., 1983; Lorincz et al., 1987; McCance et al., 1983 McCance et al., , 1985 Reid et al., 1987) . Within tumours, HPV DNA is often found to be integrated, although it is episomal within precursor lesions (Shirasawa et al., 1988) . Integration usually occurs within the E1 and E2 open reading frames (ORFs) whereas the E6 and E70RFs invariably remain intact (Baker et al., 1987; Choo et al., 1987; Matsukara et al., 1986; Schneider-Maunoury et al., 1987; Tsunokawa et al., 1986) . The HPV-16 and -18 E6 and E70RFs are transcriptionally active in tumours (Schwarz et al., 1985; Smotkin & Wettstein, 1986) and protein products from these ORFs have been detected within cells (Seedorf et al., 1987; Smotkin & Wettstein, 1986) . Both the E6 and E7 ORFs are required for transformation of human ceils in vitro, although only the E70RF is required for transformation of rodent cell lines (Hawley-Nelson et al., 1989; Munger et al., 1989; Watanabe et al., 1989) . The importance of the E6 and E7 genes in maintaining a transformed phenotype is supported further by one study that used inducible plasmids expressing HPV-18 E6/E7 antisense RNA to suppress E6/E7 mRNA production within HPV-18-containing C4-1 cells; induced cells exhibited reduced cell growth properties in vitro (von Knebel Doerberitz et al., 1988) .
All the E6/E7 transcripts found within the HPV-16containing SiHa and CaSki cell lines (Yee et al., 1985) and other HPV-16-positive cervical tumours have been reported to start at a position adjacent to the viral promoter P97, to contain variable splicing within the E6 ORF and then to use a splice donor site immediately 3' to the E70RF (Pater & Pater, 1988; Smotkin & Wettstein, 1986; Smotkin et al., 1989; Spence et al., 1988) . Since most viral DNA is integrated in the E1 or E20RFs, the 3' ends of these transcripts and their polyadenylation sites are usually derived from cellular sequences. In CaSki cells, the E6/E7 transcripts are spliced to a viral splice acceptor region within the E20RF and extend into the E2/E40RF region before terminating in cellular sequences including a cellular polyadenylation site.
Since tumours are pleomorphic in their histopathological appearance and variable in their behaviour, it is 0000-9976 © 1991 SGM likely that such descriptions of transcription within tumours involving extracted RNA represent only an overview of what is happening at a cellular level. Different areas within each tumour may express different types and levels of RNA which may correlate with differences in the histopathological appearance and behaviour of the tumour. We have used 125I-labelled HPV-16 subgenomic riboprobes and in situ hybridization to identify transcripts within genital carcinomas at the cellular level. In addition, metastases from two tumours were available for detailed analysis.
Our results are consistent with the reported transcription patterns in SiHa and CaSki cells and, in addition, we detected a nuclear signal representing intron sequences. E6/E7 RNA was detectable in all HPV-16-positive tumours although the presence of El, E2 and E4 RNA transcripts varied from tumour to tumour. An unexpected finding was the presence of antisense RNA in three of the eight tumours examined.
Methods
Patients and cell lines. Formalin-fixed, paraffin-embedded blocks from patients with non-glandular genital carcinomas were screened by in situ hybridization for the presence ofHPV RNA homologous to types 6, 11, 16, 18, 31 and 33. Over 80% of cervical carcinomas had detectable HPV RNA (unpublished results). Seven cervical and one vulval carcinoma containing HPV-16 RNA were chosen for further analysis. In two patients, metastases were available for analysis; one was a lymph node metastasis detected during hysterectomy and the other was a mesenteric metastasis detected 2 years after primary diagnosis and treatment. A small amount of frozen tissue from tumours 6 and 7, which had been stored at -70 °C for 6 months and 3 years respectively, was available for total RNA extraction. One HPV-16-positive, formalin-fixed vulval intraepithelial neoplasia (VIN) biopsy, graded VIN 2/3, was used as a positive control. CaSki (250 copies of HPV-16 DNA/celI) and SiHa (1 or 2 copies of HPV-16 DNA/celI) cell lines were obtained from the American Type Culture Collection.
HPV-16 subgenomic probes. All subgenomic probes were derived from a full-length clone of HPV-16 in pBR322 (a gift from Drs L. Gissmann and H. zur Hausen) . Subgenomic restriction fragments were made using restriction enzyme site maps generated from the published sequence of HPV-16 (Seedorf et al., 1985) and these were cloned into pGEM3-Blue (Promega Biotec). The probes used and the map positions of the beginning and end of each probe are illustrated in Fig 1. The identity and orientation of each clone was confirmed by restriction enzyme digestion and each probe was shown to hybridize to the appropriate fragment of total BamHI-and PstI-digested HPV-16 DNA by Southern blotting. In addition, partial double-stranded sequencing of the E5 and E6 probes using a T7 primer confirmed the predicted vector and insert sequences and their orientation. All plasmids were linearized prior to transcription.
Radiolabelling methods.
[125I]CTP (40 ~tCi) (NEN-Dupont; 2200 Ci/mmol) was dried and incorporated into riboprobes using SP6 or T7 polymerase (Promega), according to the method supplied by the manufacturer except that the reaction volume was reduced by 50% to produce probes of higher specific activity. After incubation, the template was digested with RQ1 (RNase-free) DNase (Promega) for 15 rain at 37 °C and the reaction products were treated with 50 mM-NaHCO3, 50 mM-Na~CO3 for various times to reduce the probe size to 200 to 250 bases. Hydrolysis was stopped by the addition of one-tenth of a volume of 3 M-sodium acetate pH 4.6. The probes were ethanolprecipitated with 200 ~tg salmon sperm DNA as carrier, washed twice in 70~ ethanol and then resuspended in 10 to 20 I11 double distilled water and counted. Final specific activity was approximately 8 × 108 c.p.m./~tg RNA.
In situ hybridization (ISH). HPV-16-positive CaSki cells and SiHa cells were grown on 3-aminopropyltriethoxysilane (APES)-coated glass slides until semi-confluent, washed in phosphate-buffered saline (PBS), fixed for 5 min in 4~ paraformaldehyde, 5 m-~-MgClz in PBS, air-dried for 30 min, refixed in paraformaldehyde and stored for less than 2 days in 70~ ethanol before use. Sections (5 txm) of formalin-fixed, paraffinembedded tumour biopsies were placed on APES-coated slides. The tissue sections were dewaxed in xylene, rehydrated through ethanol, refixed in 4% paraformaldehyde for 5 min and then washed four times for 5 rain each in PBS. RNase pretreatment of slides was performed, when required, using 100 ~tg/ml RNase A (Boehringer Mannheim) in 2 × SSC (0.3 M-sodium chloride, 0.03 M-sodium citrate) at room temperature for 60 rain, followed by washing in PBS.
Formalin-fixed sections were then treated with 25 ~tg/ml proteinase K, and cell smears with 1 ixg/ml proteinase K, in 10 mM-Tris, 1 mM- Antisense HPV transcripts in genital cancers 887 EDTA pH 8.0 for 15 min at 37 °C, washed in PBS and refixed in 4~ paraformaldehyde. All sections were acetylated in 0.25% acetic anhydride in 100 mM-triethanolamine pH 8.0 for 10 min. Slides were washed, dehydrated through graded ethanols and air-dried. Probe mix [2.5 ~tl containing 50~ formamide, 10% dextran sulphate, 500 ttg/ml salmon sperm DNA, 250 Ixg/ml tRNA, 3 mM-KI, 20 mM-DTT, 1 unit (U)/Ixl RNasin, 10 mg/ml bovine serum albumin (nuclease-free), 2 × SSC, 100 mM-Tris-HC1 pH 7.6, 10 mM-Na2HPO4, 10 mM-NaH2PO4, 0.01% Ficoll and 0.1 ~ polyvinylpyrrolidone, plus 50000 to 100000 d.p.m./Ixl 125I-labeiled probe (final concentration 0.05 to 0.1 ng/Ixl)] was placed on the section, covered with a 13 mm round siliconized coverslip and placed under liquid paraffin. In experiments in which viral DNA detection was required, RNase-pretreated slides were denatured by heating the slides in the paraffin-filled tray to 95 °C for 5 min before hybridization; in all other experiments slides were not denatured. Slides were then hybridized for 16 h at 50 °C. After hybridization, slides were washed three times in chloroform for 5 min each time, air-dried, washed in 2 x SSC, 100 ttM-KI to remove the coverslips, treated with RNase A (1 p.g/ml) in 5 x SSC at 37 °C for 15 min, washed four times for 30 min in 0.1 x SSC at room temperature and four times for 15 min in 0.1 x SSC at 62 °C. The dried slides were dipped in Ilford K2 emulsion and exposed in light-tight boxes at 4 °C for 1 to 2 weeks. Slides were developed with Kodak D19 developer and Rapid fixer, stained with Gill's haematoxylin and eosin and mounted in Depex.
Specificity of the ISH signal was established by using an unrelated probe of similar GC content, duck hepatitis B virus (DHBV; SP65-5.2, a gift from Dr J. Pugh) (Tuttleman et al., 1986) and by comparison with stromal tissue within each section. Both the above negative controls typically showed 0 to 3 grains per cell; a positive signal was defined as a grain count per cell threefold greater than that obtained with the DHBV probe in the same area of an adjacent section.
Antigen detection. Paraffin sections wei'e dewaxed in xylene, rehydrated through graded ethanols, quenched in 0.6~ H202 in methanol, washed in PBS and blocked with 3~ normal goat serum. Tissues were incubated at 4 °C overnight with the optimal dilution of either polyclonal rabbit anti-papillomavirus group antigen sera (Dako) or a monoclonal antibody (CAMVIR 1) directed against the aminoterminal half of the HPV-16 L1 protein expressed as a fl-galactosidase fusion protein (Banks et al., 1987 ) (a gift from Dr M. Stanley, Department of Pathology, University of Cambridge, U.K.). Bound antibody was detected using biotinylated goat anti-rabbit (Vector Laboratories) or biotinylated horse anti-mouse (Vector) Ig, followed by streptavidin-biotinylated horseradish peroxidase complex (Amersham) and diaminobenzidine (Sigma). (Kreig & Melton, 1987) . RNA was extracted from frozen tissue of tumours 6 and 7 and from CaSki, SiHa and HeLa cells according to the method of Chomczynski & Sacchi (1987) , except that all RNA preparations were further treated with 50 U/ml RQ1 DNase (Promega) for 15 min at 37 °C prior to hybridization. 32p. labelled E7 or E2/E4 riboprobes of both senses were run on a 6~ polyacrylamide/8 M-urea gel and a single band was excised and eluted in 500 ttl double distilled water with 2 ttl RNasin (Promega) at 65 °C for 4 h. Either probe (105 c.p.m.) was hybridized to 10 to 20 ~tg total extracted cell RNA at 55 °C for 16 h in 30 ~tl 80~ formamide, 0-4 M-NaCI, 40 mM-PIPES pH 6.4, 1 mM-EDTA. Next, 360 p.l RNase digestion buffer (0.3 M-NaCI, 10 mM-Tris pH 8, 5 mM-EDTA, 5 Ixg/ml RNase A) was added and the mixture was incubated at 37 °C for 15 min, followed by the addition of 10 ttl 20~ SDS containing 50 ~tg proteinase K and further incubation for 15 min. Following phenol extraction and ethanol precipitation with 20 ttg yeast tRNA, the pellet was dissolved in 10 ttl 90~ formamide loading buffer, denatured at 80 °C for 5 rain and loaded onto a 6% polyacrylamide/8 M-urea gel. The gel was washed in 10~ acetic acid and then in 20% ethanol, dried and exposed for 4 days to Kodak X-Omat RP film.
RNase protection assay

Results
Transcription in CaSki and SiHa cells
CaSki and SiHa cells were hybridized to all HPV-16 subgenomic probes with and without denaturation but without an RNase pretreatment step. The results are summarized in Table 1 and demonstrate evidence of transcripts involving all ORFs up to and including E2/E4 in CaSki cells but with minimal E2 and no E2/E40RF transcription in SiHa cells. No significant antisense signal was present and, following denaturation, SiHa cells did not demonstrate positive nuclear signals after 2 months exposure whereas CaSki cells contained a strong nuclear signal localizing to between three and five discrete areas within the nucleus after 1 to 2 weeks exposure (see Fig. 2 ).
Transcription in a VIN 2/3 lesion
Sections from a VIN grade 2/3 lesion contained abundant sense RNA corresponding to all recognized genes but not the non-coding region (NCR). Widespread transcription of all recognized genes is consistent with productive infection in this lesion and both the L1 and L2 probes produced strong signals in superficial areas corresponding to those containing L1 antigen detected by immunoperoxidase (data not shown). Low level signals with antisense probes were detectable in superficial cells containing high DNA copy numbers.
Transcription in invasive genital carcinomas
Transcription patterns were analysed in seven cervical and one vulval carcinoma and the results are summarized in Table 1 . In addition, metastases from two of the tumours were available for examination. The transcription patterns detected are divisible into two groups.
(i) Group 1
Five tumours contained almost entirely mRNA sense signal corresponding to the E6 and E70RFs, plus a nuclear E10RF signal in tumours 1 and 5 (Table 1) . There was weak hybridization to opposite strand probes in two tumours only (tumours 2 and 5) and, after denaturation, weak signal could be detected only in tumours 1 and 5, consistent with a low DNA copy number. In tumour 2, a moderately well differentiated squamous cell carcinoma (SCC), E6/E7 RNA was confined to the basal layers with no evidence of transcription of early or late genes in the differentiating layers. Conversely, tumour 5, although displaying a high level signal with the E6, E7 and E1 probes and having no significant signal with the E2 and E2/E4 probes, did display a nuclear signal with the L2, L1 and NCR probes.
(ii) Group 2 Three tumours were notable owing to the presence of unusually high levels of distinct focal nuclear signals detectable with mRNA sense probes (antisense signal) from all ORFs, and including the NCR. Tumours 7 and 8 contained discrete areas (approximately 5 to 10~ of the total surface area of the section) containing a high level signal with the sense probes (see Fig. 3 ) whereas in tumour 6 the positive cells were scattered more randomly. In tumour 6, different regions of the section contained between 1 ~ and 30 ~ of cells expressing antisense signals (see Fig. 4 ). In every case the cells containing antisense RNA displayed this signal with all sense probes used without clearly defined variations in transcript level from one area of the genome to another. This signal was characteristic in that it was obviously nuclear and, moreover, confined to a discrete focus within the nucleus; it was usually far stronger than the m R N A sense signal. Following RNase pretreatment, the antisense R N A signal was, in all three cases, abolished or diminished at least five-to 20-fold. In duplicate RNasepretreated sections a markedly increased signal was seen if slides had been denatured following RNase pretreatment and compared to slides undergoing RNase treatment alone, confirming that the probes were still intact following RNase treatment. No increased signal was detected in these areas with the control DHBV probe, excluding non-specific hybridization to areas of increased transcription.
Examination of metastases
Metastases from tumours 6 and 8 were examined using riboprobes to all ORFs with and without RNase pretreatment and D N A denaturation steps. The mesenteric metastasis from tumour 8, removed 2 years after the initial diagnosis, contained a transcription pattern identical to that described for the area (area A) of tumour expressing low levels of antisense RNA. The lymph node metastasis in tumour 6, removed during the staging hysterectomy, contained an R N A transcription pattern identical to the primary tumour with areas of both high and low expression of antisense R N A (data not shown).
RNase protection assay
Purified total R N A extracted from the cell lines and two tumours (6 and 7) containing antisense signal by ISH was denatured and hybridized in solution to 32p-labelled single-stranded riboprobes of either sense from the E7 ORF (data not shown). Similarly, in a second assay probes from the E2/E4 region were used (see Fig. 5 ). Following RNase digestion, the undigested, labelled probe sequences were detected after gel electrophoresis.
In control assays where probes were hybridized with HeLa cell R N A or yeast tRNA, no (E7 gel; data not shown) or trace amounts of (E2/E4 gel; see Fig. 5 , lanes 8 and 9) RNase-resistant probe remained, demonstrating 
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Tumour 5 ¶ that the probes themselves were not contaminated with opposite sense sequences that may have arisen from spurious transcription of the opposite strand during probe generation or from laboratory contamination. The bands present after hybridization with the HeLa RNA were the full probe length including the multiple cloning site sequence, and represent residual (< 0.1%) undigested probe probably resulting from the greater amount of HeLa cell RNA (20 ktg) used in the assay. Using the E7 probes, protection of the antisense probe was seen with CaSki, SiHa, tumour 6 and tumour 7 RNA (data not shown). The E7 sense probe was fully digested in experiments with cell lines and tumour 7 RNA but a band corresponding to approximately 250 bases (i.e. approximately the full length of the E7 sequence contained within the probe) was protected by tumour 6 RNA (data not shown).
Using the E2/E4 probes, protection of the antisense probe was seen with CaSki (see Fig. 5 , lane 5) and tumour 7 RNA (lane 13; band size approximately 220 bases, expected 225 bases) but not with SiHa (lane 7) or tumour 6 RNA (lane 11). Absence of protection of the antisense E2/E4 probe by tumour 6 RNA despite an apparent positive ISH signal with that probe is sugges-tive of this particular ISH signal being due to partial DNA denaturation. This is consistent with the high HPV DNA copy number present in this tumour (500 copies/cell; dot blot data not shown). Further ISH experiments with and without RNase pretreatment and using antisense probes are required to clarify this aspect. Protection of the mRNA sense E2/E4 probe was again seen only with tumour 6 RNA (lane 10; band size 200 bases, expected 225 bases).
Protection of the less than full-length sense E2/E4 probe sequence may have occurred if the target antisense RNA had undergone post-transcriptional modification or, alternatively, if it had been transcribed from deleted or rearranged HPV-16 DNA sequences which were present in the tumour but were distinct from those used for sense RNA transcription. Lack of RNase protection evidence for antisense RNA in tumour 7 was not unexpected because areas positive for antisense transcription by ISH constituted less than 5 % of the area of tumour tissue seen in the section. In contrast, all cells had detectable E7 and E2/E4 sense RNA by ISH which was confirmed by RNase protection.
Group 2 tumours therefore displayed unexpectedly high levels of sequences hybridizing with sense probes; 
* Sections were processed by one of four methods: (i) undenatured, no RNase pretreatment, hybridized with antisense riboprobes; (ii) undenatured, no RNase pretreatment, hybridized with sense riboprobes; (iii) undenatured, RNase-treated, hybridized with sense riboprobes; (iv) denatured, RNase-treated, hybridized with sense riboprobes.
t Grain counts from a 6 day exposure. Scored as + + + +, > 100 grains/cell; + + +, 51 to 100 grains/cell; + +, 21 to 50 grains/cell; +, 11 to 20 grains/cell; +, < 10 grains/cell but more than a control; -, not greater than a control.
:~ ND, Not done. § These tumours were undifferentiated.
[1 These tumours were moderately differentiated SCCs. ¶ These turnours were poorly differentiated SCCs. ** Different areas of the same section giving different patterns were scored separately (areas A and B). tt NA, Not assessed because comparable areas were exhausted during serial sectioning.
these sequences were susceptible to RNase pretreatment of the sections and were confirmed in one tumour, by the RNase protection assay, as representing antisense RNA.
Antigen detection
No tumour contained evidence of late gene expression detectable using either the commercially available papillomavirus group antigen antisera or the monoclonal antibody to HPV-16 L1 antigen (data not shown).
Discussion
Our findings are in agreement with the reported integration sites, deletions and transcript sequence data reported for the CaSki and SiHa cell lines (Baker et al., 1987; Smotkin & Wettstein, 1986; Smotkin et al., 1989; Spence et al., 1988) . Both cell lines contain E6 and E7 gene transcripts, the most frequent of which is reported to contain a 183 base intron (nucleotides 226 to 409) within the E60RF. The presence of this intron within the region covered by the E6 probe (nucleotides 112 to 498) may explain the consistently weaker signal, seen in both cell lines and tumours, with the E6 probe than with the E7 probe (nucleotides 622 to 875). Cytoplasmic transcripts in CaSki ceils hybridizing to the E2/E4 probe but not the E5 probe result from splicing of the E6 and E7 transcripts to downstream exons in the E2 and E2/E4 ORFs, and termination of these transcripts at nucleotide 3731, 5' to the E5 probe sequence. Diminished E5 signal in the subsequent analysis of transcription in tumours is, however, more likely to be secondary to the low GC content of this region. The washing conditions used in these experiments were effectively at or above the calculated Tm of the E5 probe while being 5 to 10 °C below the Tm for all of the other probes. 6 and 7) , HeLa cells (lanes 8 and 9), tumour 6 (lanes 10 and 11) and tumour 7 (lanes 12 and 13) .
The presence of nuclear E1 and E2 signals in both SiHa and CaSki represents detection of unspliced transcripts or undegraded intron sequences, as has been reported previously with probes for the E 1 0 R F in HPV-16-positive cervical intraepithelial neoplasia lesions (Crum et al., 1988) and HPV-11 genital condylomas (Chow et al., 1987) . In SiHa cells the E2 signal results from transcripts covering the retained 5' region of the E2 ORF upstream of the integration site at nucleotide 3132. In neither cell line was there in situ evidence of signal detected by the m R N A sense probes (except for an equivocal signal with the E2/E4 probe not confirmed by the RNase protection assay). However, in denatured CaSki cells strong nuclear signals that represent viral D N A were obtained with m R N A sense probes from all regions of the genome. No signal was detected in SiHa cells following denaturation.
Analysis of the eight tumours revealed distinct differences in their transcription patterns. Although all tumours had detectable E7 sense R N A and all but one had E6 sense RNA, significant ISH signals consistent with E2/E4 sense transcripts were absent from five tumours (tumours 1, 2, 3, 4 and 5), and present in two (tumours 7 and 8). Presence or absence of E2/E4 sense transcripts could not be definitively determined in the high D N A copy number tumour 6 in which, despite significant E2/E4 in situ sense signal, E2/E4 sense R N A was not confirmed by the RNase protection assay. The absence of E2/E4 transcripts from five of the eight tumours is consistent with the hypothesis that integration occurs preferentially in the E 1 or E 2 0 R F s (Baker et al., 1987; Choo et al., 1987; Matsukura et al., 1986; Schneider-Maunoury et al., 1987; Tsunokawa et al., 1986) , although E2 and E4 transcripts may still be generated in some tissues if episomal viral D N A persists. In situ detection of E 2 / E 4 0 R F expression in five of seven HPV-16-positive SCCs was reported by Stoler et al. (1990) . Larger numbers of tumours need to be tested to determine the frequency of E2/E4 gene expression and/or integration in HPV-16-positive tumours, and its effect on tumour behaviour.
Sense signal was detectable with the late ORF probes in two tumours (tumours 5 and 6). In tumour 6, denaturation of high copy number D N A may be responsible for the apparent late gene expression. The signal in turnout 5 however is unique. This tumour contains only a low, almost undetectable, D N A copy number and demonstrates only weak signal with the sense probes; nevertheless intense nuclear signal was seen with the L1 antisense probe and lesser signals with L2 and N C R probes. Since the absence of E2 and E2/E4 signals may be due to integration in the E1 or E2 genes, transcription of the late region and N C R is likely to be due to integration near an active host cell promoter without processing of R N A from the L2, L1 and N C R region. No evidence of capsid antigen was detected in this tumour.
Use of the sense R N A probes allowed division of the hybridization patterns into two groups, those with predominantly sense signal only and a group of tumours which were distinct in that they had disproportionately strong signals with m R N A sense riboprobes. Other authors have reported ISH signals using HPV sense riboprobes on HPV-infected tissue that have been attributed to denaturation of viral D N A during tissue fixation, processing or hybridization (Crum et al., 1988; Stoler & Broker, 1986) . This was evident in the VIN lesion but is unlikely to account for the majority of the antisense signal in the last group of tumours.
Since the sense and antisense probes were of identical size, specific activity and concentration, denatured D N A should give identical signals with both sense and antisense probes; this was not seen and, moreover, the differences in intensity were large, generally more than fivefold but up to 50-fold greater (in tumour 8) with the sense probes. The distribution within the cell was also quite different.
The antisense signal was RNase-susceptible. This reduction was shown not to be due to subsequent digestion of riboprobe by residual RNase because a strong D N A ISH signal was still obtained in duplicate sections that were denatured after RNase treatment, indicating that intact probe was still present.
The RNase protection assay confirmed the presence of antisense RNA corresponding to ORFs E7 and E2/E4 in tumour 6. Although the assay failed to detect antisense RNA in tumour 7, this block contained only a small focus of antisense RNA signal that was quickly exhausted in serial sectioning for ISH. It is probable that the biopsy used for RNA extraction similarly contained only a small percentage of cells demonstrating antisense transcription. Insufficient RNA was extracted from the small amount of frozen tissue available to attempt additional confirmation by Northern blotting and probing with subgenomic riboprobes.
The higher level of signal found in the group 2 tumours following denaturation suggests that these tumours may also have greater than the average DNA copy number. This may lead to an increased chance of integration adjacent to active cellular promoters and hence nonvirally controlled transcription. In contrast, the 'orderly' pattern of transcription in the low DNA copy number/ transcription group 1 tumours may reflect the low probability of integration adjacent to active cellular promoters. However, ISH estimates of DNA copy number may be inaccurate in the group 2 tumours. RNase pretreatment was often incompletely effective at abolishing the antisense signal and the denaturation step may allow denaturation of RNase-resistant sense or antisense RNA hybrids leading to deceptively high estimates of viral DNA copy number.
In vitro studies expressing antisense RNA to the HPV-18 E6 and E70RFs in C4-1 cells have shown that antisense RNA expression is associated with reduced cell growth (von Knebel Doeberitz et al., 1988) . We might postulate, therefore, that cells expressing antisense RNA may be at a growth disadvantage within the tumours. To test this hypothesis we examined two metastases from patients 6 and 8. In patient 8 the mesenteric metastasis contained no evidence for antisense RNA expression whereas in patient 6 the lymph node metastasis contained antisense RNA expression identical to the primary tumour; however, no trend was evident. No correlation was seen between the histological grade of tumour differentiation and the presence of antisense RNA.
Naturally occurring antisense RNA in prokaryotic systems can regulate gene expression at a variety of levels (Inouye, 1988) . In eukaryotes it has been described in at least four systems. It is reported to be involved in regulating the stability of basic fibroblast growth factor mRNA in xenopus oocytes (Kimelman & Kirschner, 1989) . In a second system, regulation of p53 protein production in murine erythroleukaemia ceils was accompanied by synthesis of a polyadenylated RNA transcript orientated in an antisense manner to the p53 RNA and mapping to the first intron of the p53 gene (Khochbin & Lawrence, 1989) . Antisense transcripts have also been described in two viral systems. In herpes simplex virus infections viral latency in the dorsal root ganglia is associated with transcription of RNA complementary to the ICP-0 mRNA. This latency-associated transcript (LAT) is not significantly polyadenylated nor is it associated with any protein product and its role in the establishment of latency remains unclear (Ho & Mocarski, 1989; Stevens et al., 1987) . Lastly, Epstein-Barr virus gene expression in a nasopharyngeal carcinoma-derived cell line includes expression of transcripts complementary to genes encoding functions associated with replication (Hitt et al., 1989) .
The antisense transcripts we found in cervical tumours do not correspond to any recognized HPV transcripts but rather extend across the whole genome. We do not know their size, although the size of the products detected in one RNase protection assay suggests that transcripts of less than full length may be produced. We do not know whether cellular antisense transcripts are also involved, although hybridization of tumour 6 with probes for interferon • and retinoblastoma RNA did not reveal any evidence of antisense transcripts, suggesting this is not simply a non-specific deregulation of cell transcription (data not shown). It is not known whether they are polyadenylated; if not (like the LAT transcript in latent herpesvirus infections), this may explain why they have not been detected previously in studies of poly(A) ÷ RNA extracted from HPV-positive tumours, and their nuclear localization. Further studies on total and polyadenylated RNA extracted from additional tumours will be required to answer these questions. The biological significance of these transcripts is unclear. The finding of nuclear sense L2, L1 and NCR RNA transcripts in tumour 5 suggests the possibility that both the late ORF sense transcripts and the antisense transcripts may be incidental findings derived from integration adjacent to active cellular promoters. Similarly, the absence of clearly defined areas in the genome transcribing antisense RNA is in favour of the absence of control of transcription by viral promoters and regulatory elements. The localization of antisense transcription within discrete areas of tumours 7 and 8 suggests that variations in transcription may be related to clonal diversity of subpopulations of cells within the tumour. Lastly, the clinical significance of these transcripts remains to be determined.
Our findings therefore provide the first evidence for naturally occurring antisense transcripts in HPV-positive genital infection, with the implication that such molecules may be natural modulators of cell growth in a manner analogous to the in vitro model system already described (von Knebel Doeberitz et al., 1988) .
